Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment

被引:50
作者
Oldroyd, Alexander [1 ,2 ]
Lilleker, James [2 ,3 ]
Chinoy, Hector [2 ,4 ]
机构
[1] Univ Manchester, Ctr Musculoskeletal Res, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England
[2] Manchester Acad Hlth Sci Ctr, Cent Manchester NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England
[3] Greater Manchester Neurosci Ctr, Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Salford, Lancs, England
[4] Manchester Acad Hlth Sci Ctr, Salford Royal NHS Fdn Trust, Salford, Lancs, England
基金
英国医学研究理事会;
关键词
Dermatomyositis; idiopathic inflammatory myopathies; inclusion body myositis; myositis; polymyositis; INCLUSION-BODY MYOSITIS; CLINICAL-FEATURES; CANCER-RISK; LUNG-DISEASE; DERMATOMYOSITIS; POLYMYOSITIS; COHORT; AUTOANTIBODIES; CLASSIFICATION; MANIFESTATIONS;
D O I
10.7861/clinmedicine.17-4-322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The idiopathic inflammatory myopathies are a group of conditions characterised by inflammation of muscles (myositis) and other body systems. The diagnosis can be challenging because of the many potential clinical features and extra-muscular manifestations, which may be seemingly unrelated. An accurate diagnosis requires up-to-date understanding of the clinical manifestations, different clinical subtypes and appropriate interpretation of investigations, including newly described serological subtypes. This review will detail the approach to the diagnosis of an idiopathic inflammatory myopathy, based on up-to-date knowledge. The recently updated classification criteria and treatment options will also be described.
引用
收藏
页码:322 / 328
页数:7
相关论文
共 30 条
[1]   Inclusion body myositis - Clinical features and clinical course of the disease in 64 patients [J].
Badrising, UA ;
Maat-Schieman, MLC ;
van Houwelingen, JC ;
van Doorn, PA ;
van Duinen, SG ;
van Engelen, BGM ;
Faber, CG ;
Hoogendijk, JE ;
de Jager, AE ;
Koehler, PJ ;
de Visser, M ;
Verschuuren, JJGM ;
Wintzen, AR .
JOURNAL OF NEUROLOGY, 2005, 252 (12) :1448-1454
[2]   Myositis-specific autoantibodies: an important tool to support diagnosis of myositis [J].
Betteridge, Z. ;
McHugh, N. .
JOURNAL OF INTERNAL MEDICINE, 2016, 280 (01) :8-23
[3]   POLYMYOSITIS AND DERMATOMYOSITIS .2. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (08) :403-407
[4]   POLYMYOSITIS AND DERMATOMYOSITIS .1. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) :344-347
[5]   Dermatomyositis [J].
Callen, JP .
LANCET, 2000, 355 (9197) :53-57
[6]   Diagnosis, pathogenesis and treatment of myositis: recent advances [J].
Carstens, P. -O. ;
Schmidt, J. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 175 (03) :349-358
[7]   Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan [J].
Chen, Yi-Ju ;
Wu, Chun-Ying ;
Huang, Yu-Lin ;
Wang, Chang-Bi ;
Shen, Jui-Lung ;
Chang, Yun-Ting .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
[8]   CANCER RISK FOLLOWING POLYMYOSITIS AND DERMATOMYOSITIS - A NATIONWIDE COHORT STUDY IN DENMARK [J].
CHOW, WH ;
GRIDLEY, G ;
MELLEMKJAER, L ;
MCLAUGHLIN, JK ;
OLSEN, JH ;
FRAUMENI, JF .
CANCER CAUSES & CONTROL, 1995, 6 (01) :9-13
[9]   Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome [J].
Coppo, P ;
Clauvel, JP ;
Bengoufa, D ;
Oksenhendler, E ;
Lacroix, C ;
Lassoued, K .
RHEUMATOLOGY, 2002, 41 (09) :1040-1046
[10]  
CUNNINGHAM JD, 1985, OTOLARYNG HEAD NECK, V93, P673